Market revenue in 2020 | USD 1,548.5 million |
Market revenue in 2028 | USD 2,624.5 million |
Growth rate | 6.8% (CAGR from 2020 to 2028) |
Largest segment | Mental health |
Fastest growing segment | Neurodegenerative Diseases |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer |
Key market players worldwide | Biogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.
Mental health was the largest segment with a revenue share of 42.11% in 2020. Horizon Databook has segmented the South Korea central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.
Technological advancements and increase in research activities to develop novel therapies for CNS disorders are factors anticipated to drive market growth in the coming years. Moreover, with increasing prevalence of dementia in the country, domestic pharmaceutical companies are working on new forms of drug for its treatment.
For instance, ICURE pharmaceutical has developed donepezil patch jointly with Celltrion and is to apply for approval. Government initiatives to improve the life of patients suffering from CNS disorders are also supporting market growth.
For instance, Ministry of Science & ICT and Ministry of Health & Welfare are investing to develop treatments to overcome dementia. Technological advancements in diagnosis of Alzheimer’s disease helps identify the disease at an early stage.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea central nervous system therapeutic market , including forecasts for subscribers. This country databook contains high-level insights into South Korea central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account